1nhaler raises £2.2M in funding led by Archangels to advance its lead product, 1nhaler Salbutamol, and support late-stage development.
Amount Raised
£2.2 Million
Round Type
Seed
EdinburghManufacturingBiotechnologyInvestors
Description
1nhaler, a drug delivery device developer from Edinburgh, raised £2.2M in funding. The round was led by Archangels, with participation from Scottish Enterprise and BBB Investments. This funding will facilitate late-stage development of its lead product and support clinical trials. Founded by Don Smith, 1nhaler focuses on innovative inhalation solutions for various medical conditions.
Quick answer
1nhaler raised £2.2 Million in a Seed round, dated November 3, 2026. Investors: Scottish Enterprise, BBB Investments and Archangels. 1nhaler is based in Edinburgh, Scotland, United Kingdom.
- How much did 1nhaler raise?
- 1nhaler raised £2.2 Million in a Seed round on November 3, 2026.
- Who invested in 1nhaler?
- Scottish Enterprise, BBB Investments and Archangels are named as investors in this round.
- What does 1nhaler do?
- 1nhaler is developing a single-dose dry-powder inhaler that is simple to use, low-cost, and compact enough to fit in a wallet.
- Where is 1nhaler based and how big is it?
- 1nhaler is based in Edinburgh, Scotland, United Kingdom. Fundz records about 5 employees.
- Who are the decision-makers at 1nhaler?
- Fundz holds 1 contact at 1nhaler. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Manufacturing and Biotechnology around the same time
Companies in the same sectors as 1nhaler that raised within 45 days of this round, from Fundz verified event records.
- XTPL raised $6.5M on November 13, 2026.
- Biomatter raised $18M (Series A) on November 12, 2026.
- Mosaic Intelligence Labs raised $47M (Seed) on November 10, 2026.
- FluoRok raised $30M (Series A) on November 5, 2026.
- altM raised $10M (Series A) on November 5, 2026.
- Alt Material Innovations Private Limited raised $318K (Series A) on November 4, 2026.
Who to call at 1nhaler, and when
A new round usually means 1nhaler is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day 1nhaler raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at 1nhaler, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at 1nhaler. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment 1nhaler raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
1nhaler raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.